Jury rules in favor of Bayer's Monsanto in Philadelphia trial over Roundup
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 12 2024
0mins
Should l Buy ?
Source: Yahoo Finance
Court Verdict: A Philadelphia Court jury ruled in favor of Bayer's Monsanto unit in a product liability trial concerning Roundup weed killer.
Litigation Background: Bayer, which acquired Monsanto for $63 billion in 2018, has been involved in extensive litigation regarding claims that Roundup causes cancer.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
